This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Innovations of Aaron A Momose
Introduction
Aaron A Momose is an accomplished inventor based in Blue Bell, PA (US). He has made significant contributions to the field of oligonucleotide delivery systems. His innovative work has led to the development of a unique patent that addresses important challenges in this area.
Latest Patents
Aaron A Momose holds a patent for "Single chemical entities and methods for delivery of oligonucleotides." This invention discloses a modular composition that includes an oligonucleotide, one or more linkers, and one or more peptides. The linkers can be attached to the oligonucleotide at any 3' and/or 5' end. Additionally, the composition may include lipids, solubilizing groups, and/or targeting ligands attached to the oligonucleotide. This patent showcases his innovative approach to enhancing the delivery of therapeutic oligonucleotides.
Career Highlights
Aaron A Momose is currently employed at Merck Sharp & Dohme Corporation, a leading global healthcare company. His work at Merck has allowed him to collaborate with other talented professionals in the field. His contributions have been instrumental in advancing research and development in pharmaceutical sciences.
Collaborations
Some of his notable coworkers include Jeffrey G Aaronson and Stanley F Barnett. Their collaborative efforts have further enriched the research environment at Merck and have led to significant advancements in their respective fields.
Conclusion
Aaron A Momose is a notable inventor whose work in oligonucleotide delivery systems has made a meaningful impact in the pharmaceutical industry. His innovative patent and contributions at Merck Sharp & Dohme Corporation highlight his dedication to advancing medical science.